US regulators recommend ‘pause’ in use of J&J vaccine over blood clot fears

Top US health authorities have recommended a “pause” in the use of the Johnson & Johnson COVID-19 vaccine “out of an abundance of caution” as they investigate any links between it and blood clots, a regulator says.

The US Food and Drug Administration and the Centers for Disease Control are assessing the “potential significance” of six reported cases of a rare blood clot in patients who have received the shot, the FDA tweets. “Until that process is complete, we are recommending this pause,” it says.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.